{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:59:07Z","timestamp":1791273547794,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.diagmicrobio.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:31:52Z","timestamp":1416875512000},"page":"259-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species"],"prefix":"10.1016","volume":"81","author":[{"given":"M.A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Rhomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0005","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0135","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.01711-09","article-title":"Low prevalence of fks1 hotspot 1 mutations in a worldwide collection of Candida spp","volume":"54","author":"Castanheira","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0160","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.00574-07","article-title":"Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei","volume":"52","author":"Chaturvedi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0205","series-title":"M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0210","series-title":"M27-S4. Reference method for broth dilution antifungal susceptibility testing of yeasts: 4th informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0170","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0090","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jac\/dkh434","article-title":"Combinations of antifungal agents in therapy\u2014what value are they?","volume":"54","author":"Cuenca-Estrella","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","article-title":"Candida spp. with acquired echinocandin resistance, France, 2004\u20132010","volume":"18","author":"Dannaoui","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0040","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.00443-09","article-title":"Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint","volume":"53","author":"Garcia-Effron","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0035","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1128\/AAC.00998-09","article-title":"Novel FKS mutations associated with echinocandin resistance in Candida species","volume":"54","author":"Garcia-Effron","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1074-5521(02)00092-3","article-title":"Deacetylase enzymes: biological functions and the use of small-molecule inhibitors","volume":"9","author":"Grozinger","year":"2002","journal-title":"Chem Biol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"Grunstein","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2958.2012.08194.x","article-title":"CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction","volume":"86","author":"Healey","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0175","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1126\/science.1119321","article-title":"Cell biology. A fungal Achilles' heel","volume":"309","author":"Heitman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1574-6968.2008.01072.x","article-title":"Chemosensitization of fungal pathogens to antimicrobial agents using benzo analogs","volume":"281","author":"Kim","year":"2008","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0050","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/AAC.01102-12","article-title":"Optimizing echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations","volume":"56","author":"Lepak","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0190","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/dkm493","article-title":"In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves","volume":"61","author":"Li","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0120","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bmcl.2006.12.028","article-title":"Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans","volume":"17","author":"Mai","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0195","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0200","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/AAC.42.9.2342","article-title":"Synergy of nitric oxide and azoles against Candida species in vitro","volume":"42","author":"McElhaney-Feser","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb9000","first-page":"5.18.1","article-title":"Synergism testing. Broth microdilution, checkerboard, and broth macrodilution methods","volume":"vol. 1","author":"Moody","year":"1991"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1568011054866946","article-title":"Histone deacetylase inhibitors: latest developments, trends and prospects","volume":"5","author":"Moradei","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0025","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cid\/cit140","article-title":"Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida","volume":"56","author":"Ostrosky-Zeichner","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12281-011-0054-x","article-title":"Echinocandin-resistant Candida: Molecular methods and phenotypes","volume":"5","author":"Perlin","year":"2011","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0070","first-page":"74","article-title":"Azole antifungal drug cross-resistance: mechanisms epidemiology, and clinical significance","volume":"1","author":"Pfaller","year":"2007","journal-title":"J Invasive Fungal Infect"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0150","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0130","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0155","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1128\/JCM.00308-13","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0080","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2012.08.035","article-title":"Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance","volume":"2","author":"Robbins","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0215","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0180","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0055","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1128\/AAC.01686-10","article-title":"Disseminated candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin","volume":"55","author":"Slater","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0125","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/AAC.46.11.3532-3539.2002","article-title":"Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation","volume":"46","author":"Smith","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.11.008_bb0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/MMBR.64.2.435-459.2000","article-title":"Acetylation of histones and transcription-related factors","volume":"64","author":"Sterner","year":"2000","journal-title":"Microbiol Mol Biol Rev"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314004581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314004581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T19:40:20Z","timestamp":1566070820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314004581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0732889314004581"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.11.008","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}